Factors Influencing Weight Gain at Different Stages of the Fontan Pathway for Children with Functionally Single Ventricle Heart Disease - Report - MDSpire
Advertisement
Factors Influencing Weight Gain at Different Stages of the Fontan Pathway for Children with Functionally Single Ventricle Heart Disease
Determinants of Weight Increase Throughout Various Phases of the Fontan Procedure
Overview
This study investigates the factors influencing weight changes in pediatric patients with functionally single ventricle heart disease undergoing the Fontan procedure.
Background
Functionally single ventricle hearts represent a significant subgroup of congenital heart disease, necessitating staged surgical interventions. Growth faltering is a common issue in these patients, associated with poor health outcomes and increased risk of complications. Understanding the determinants of weight gain during the Fontan pathway is crucial.
Data Highlights
No numerical data is available in the provided source material.
Key Findings
Children with functionally single ventricle hearts often experience poor growth in early life.
Standardized weight and height z-scores decrease sharply from birth to Stage 2 surgery, with weight normalizing around 10–12 years post-Fontan.
Factors influencing growth include nutritional management, timing of surgical procedures, and resolution of complications.
Growth faltering is linked to inadequate intake, malabsorption, and increased metabolic demands.
Aggressive nutritional supplementation can improve growth, but its impact on long-term outcomes is not clearly established.
Clinical Implications
Healthcare providers should monitor growth closely in pediatric patients with functionally single ventricle hearts and consider aggressive nutritional strategies. Understanding the timing of surgical interventions may also help optimize growth outcomes.
Conclusion
The study underscores the need for targeted interventions to support weight gain in children undergoing the Fontan procedure, which may improve their overall health trajectory.